Stockreport

How The Cytek Biosciences (CTKB) Story Is Shifting With New Targets And 2026 Guidance [Yahoo! Finance]

Cytek Biosciences, Inc.  (CTKB) 
PDF Cytek Biosciences has seen its fair value estimate adjusted from US$5.75 to US$6.00, placing the stock in a slightly higher US$5 to US$6 price target framework. Analyst [Read more]